News & Events

Philogen publishes a new study on OncoFAP in Clinical Cancer Research

Oct 19, 2022

The study shows excellent tumor uptake of the novel OncoFAP-MMAE Small Molecule-Drug Conjugates (SMDCs) with high and selective release of the cytotoxic MMAE payload at the tumor site.

OncoFAP-based pro-drugs are currently being developed for the imaging and therapy of cancer.